Blincyto (blinatumomab) - Amgen
Epkinly (epcoritamab-bysp) - Genmab, AbbVie
Talvey (talquetamab-tgvs) - J&J
Tecvayli (teclistamab-cqyv) - Genmab, J&J
Columvi (glofitamab-gxbm) - Roche
Elrexfio (elranatamab-bcmm) - Pfizer
Lynozyfic (linvoseltamab-gcpt) - Regeneron
Lunsumio (mosunetuzumab-axgb) - Roche
https://www.sciencedirect.com/science/article/abs/pii/S2152265026030545
 
Büsranur Yilmaz MD 1,2; Alina Tariq MD 3; Tamara Hossein 4; Fatmanur Yilmaz MD 5; Bailey Grones 6
 
Sep 1, 2026
 
Prev Next